Skip to content

Our portfolio includes biosimilars for immunology, oncology, and ophthalmology indications, a nephrology product line, and a Parkinson’s franchise. Our specialty medicines account for approximately 20% of STADA’s sales, which reached an impressive EUR 3.80 billion in 2022, marking an 11% increase from the previous year.

As Europe’s fourth-largest supplier of consumer healthcare and generic medicines by sales, we are proud to serve patients in approximately 120 countries worldwide. Our team of 13,183 employees is dedicated to delivering innovative solutions that meet the evolving needs of patients and healthcare providers. Our Headquarters is located in Bad Vilbel, Germany.

For more information, please visit: www.stada.comSpecialty Pharmaceuticals | STADA

×

Join us in Prague for the 2nd edition of BOOST!

Secure your spot in the Movement for Shortage-Free World

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy—medicine shortages.